LMR Partners LLP Has $18.41 Million Stock Holdings in ProAssurance Corporation $PRA

LMR Partners LLP increased its holdings in shares of ProAssurance Corporation (NYSE:PRA) by 287.2% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 806,471 shares of the insurance provider’s stock after purchasing an additional 598,169 shares during the quarter. LMR Partners LLP’s holdings in ProAssurance were worth $18,412,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Police & Firemen s Retirement System of New Jersey increased its position in shares of ProAssurance by 6.6% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 11,021 shares of the insurance provider’s stock worth $252,000 after acquiring an additional 681 shares in the last quarter. Eisler Capital Management Ltd. boosted its stake in ProAssurance by 0.9% in the 2nd quarter. Eisler Capital Management Ltd. now owns 100,881 shares of the insurance provider’s stock worth $2,303,000 after purchasing an additional 881 shares during the period. Jane Street Group LLC increased its holdings in ProAssurance by 1.2% during the 2nd quarter. Jane Street Group LLC now owns 73,834 shares of the insurance provider’s stock worth $1,686,000 after purchasing an additional 890 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of ProAssurance by 50.7% in the 2nd quarter. GAMMA Investing LLC now owns 3,123 shares of the insurance provider’s stock valued at $71,000 after purchasing an additional 1,050 shares during the period. Finally, BNP Paribas Financial Markets raised its stake in shares of ProAssurance by 22.8% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,679 shares of the insurance provider’s stock valued at $130,000 after purchasing an additional 1,056 shares during the period. Institutional investors own 85.58% of the company’s stock.

ProAssurance Trading Up 0.4%

Shares of ProAssurance stock opened at $24.26 on Friday. The stock has a market cap of $1.25 billion, a P/E ratio of 37.32 and a beta of 0.11. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. ProAssurance Corporation has a 12-month low of $13.90 and a 12-month high of $24.41. The business’s 50 day moving average is $24.03 and its 200-day moving average is $23.75.

ProAssurance (NYSE:PRA) last released its earnings results on Friday, May 20th. The insurance provider reported $0.04 earnings per share for the quarter. ProAssurance had a net margin of 3.01% and a return on equity of 4.78%. The business had revenue of $220.02 million during the quarter. Equities research analysts predict that ProAssurance Corporation will post 0.8 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on PRA shares. Weiss Ratings reiterated a “hold (c)” rating on shares of ProAssurance in a report on Wednesday, October 8th. Zacks Research downgraded shares of ProAssurance from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 5th. Finally, Wall Street Zen raised shares of ProAssurance to a “sell” rating in a research report on Saturday, November 22nd. Five analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $25.00.

ProAssurance Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.